FIELD: pharmaceutical industry. SUBSTANCE: described are trivalent iron fumarate hydrate which shows medicinal properties in treating iron-deficient anemia and pharmaceutical composition based on said agent. Trivalent iron fumarate hydrate increases content of hemoglobin in blood with minimum side effects. EFFECT: improved properties of the pharmaceutical composition. 4 cl, 4 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT FOR ASIDEROTIC ANEMIA TREATMENT IN CHILDREN | 1994 |
|
RU2098102C1 |
| MEDICINAL AGENT FOR ASIDEROTIC ANEMIA TREATMENT | 1994 |
|
RU2098101C1 |
| POLYFUNCTIONAL BLOOD SUBSTITUTE FOR TREATMENT OF BLOOD LOSS AND SHOCK | 1998 |
|
RU2136291C1 |
| ANTIHYPOXIC MEDICINAL AGENT | 2001 |
|
RU2189813C1 |
| PHARMACOLOGICAL COMPOSITION ON BASIS OF IRON COMPOUNDS | 2016 |
|
RU2625739C1 |
| PHARMACOLOGICAL COMPOSITION FOR IRON DEFICIENCY ANEMIA TREATMENT | 2021 |
|
RU2763135C1 |
| METHOD OF PREPARING THE PRESERVING AGENT FOR ERYTHROCYTES | 1995 |
|
RU2098959C1 |
| METHOD FOR FINDING COURSE DOSE OF ELEMENTARY IRON IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY IRON DEFICIENCY | 2012 |
|
RU2478964C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION IN PREGNANT WOMEN WITH IRON-DEFICIENCY ANEMIA | 2009 |
|
RU2418589C2 |
| WOUND-HEALING SPONGE CYTOMOKOL, ITS THERAPEUTIC FORMS (VERSIONS) AND METHOD OF PREPARATION THEREOF | 1996 |
|
RU2126693C1 |
